London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Brendan Keating
)
- Job title
- Institution
- NYU Langone Health, USA
- Biography
Brendan Keating DPhil, is an Associate Professor in the Department of Surgery, and The Institute of Systems Genetics, New York University Langone Health. He completed a postdoctoral fellowship at the Institute of Translational Medicine and Therapeutics with a faculty position in the Department of Pediatrics and Surgery at UPenn, and he was also a visiting Scientist at the Wellcome Trust Sanger Institute. Brendan leads several NIH funded transplant biomarker studies, allo-transplant-related clinical trials, and multiomic studies in NYU’s pig-to-human xenotransplant program.
- Recent publications
Schmauch, E. et al. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med. 30(5):1448–1460 (2024).
DOI: 10.1038/s41591-024-02972-1Moazami, N. et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat Med. 29(8):1989–1997 (2023).
DOI: 10.1038/s41591-023-02471-9Montgomery, R.A. et al. Results of Two Cases of Pig-to-Human Kidney Xenotransplantation. N Engl J Med. 386(20):1889–1898 (2022).
DOI: 10.1056/NEJMoa2120238.
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.